1. Home
  2. IROH vs ASRT Comparison

IROH vs ASRT Comparison

Compare IROH & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IROH
  • ASRT
  • Stock Information
  • Founded
  • IROH 2021
  • ASRT 1995
  • Country
  • IROH United States
  • ASRT United States
  • Employees
  • IROH N/A
  • ASRT N/A
  • Industry
  • IROH
  • ASRT Biotechnology: Pharmaceutical Preparations
  • Sector
  • IROH
  • ASRT Health Care
  • Exchange
  • IROH Nasdaq
  • ASRT Nasdaq
  • Market Cap
  • IROH 91.2M
  • ASRT 78.3M
  • IPO Year
  • IROH 2023
  • ASRT 1997
  • Fundamental
  • Price
  • IROH $10.39
  • ASRT $0.86
  • Analyst Decision
  • IROH
  • ASRT Strong Buy
  • Analyst Count
  • IROH 0
  • ASRT 4
  • Target Price
  • IROH N/A
  • ASRT $3.19
  • AVG Volume (30 Days)
  • IROH 34.7K
  • ASRT 367.0K
  • Earning Date
  • IROH 01-01-0001
  • ASRT 03-10-2025
  • Dividend Yield
  • IROH N/A
  • ASRT N/A
  • EPS Growth
  • IROH N/A
  • ASRT N/A
  • EPS
  • IROH 0.20
  • ASRT N/A
  • Revenue
  • IROH N/A
  • ASRT $125,763,000.00
  • Revenue This Year
  • IROH N/A
  • ASRT N/A
  • Revenue Next Year
  • IROH N/A
  • ASRT $1.84
  • P/E Ratio
  • IROH $53.04
  • ASRT N/A
  • Revenue Growth
  • IROH N/A
  • ASRT N/A
  • 52 Week Low
  • IROH $9.97
  • ASRT $0.73
  • 52 Week High
  • IROH $11.11
  • ASRT $1.80
  • Technical
  • Relative Strength Index (RSI)
  • IROH N/A
  • ASRT 55.35
  • Support Level
  • IROH N/A
  • ASRT $0.78
  • Resistance Level
  • IROH N/A
  • ASRT $0.88
  • Average True Range (ATR)
  • IROH 0.00
  • ASRT 0.03
  • MACD
  • IROH 0.00
  • ASRT 0.01
  • Stochastic Oscillator
  • IROH 0.00
  • ASRT 82.60

About IROH Iron Horse Acquisitions Corp. Common Stock

Iron Horse Acquisitions Corp is a blank check company.

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: